By Business/Source
Currency:USD
2025/Q3
Stock NameRevenueRatio
OviTex Reinforced Tissue Matrix (OviTex)13.21M63.83%
OviTex Reinforced Tissue Matrix (OviTex) Plastic and Reconstructive Surgery (PRS)7.08M34.22%
Other404K1.95%
By Country/Region
Currency:USD
2024/FY
Stock NameRevenueRatio
United States59M85.14%
Outside U.S10.3M14.86%